SFG
GMAB icon

Steward Financial Group’s Genmab GMAB Stock Holding History

Steward Financial Group’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$14K Hold
416
– – ﹤0.01% 306
2023
Q2 		$15K Buy
+416
New +$16.6K ﹤0.01% 289
2022
Q3 		– Sell
-9
Closed – – 574
2022
Q2 		$0 Buy
+9
New +$292 ﹤0.01% 1121

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Steward Financial Group's GMAB Position: Q3 2023 in Review

Steward Financial Group held its Genmab (GMAB) position steady in Q3 2023 at 416 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #306.

Steward Financial Group first reported a position in GMAB in Q2 2022 and has held it in 3 quarters since. The position peaked at $15K in Q2 2023. 233 funds tracked by Wall St. Rank hold GMAB as of Q3 2023.

  • Steward Financial Group held 416 shares of Genmab worth $14K as of Q3 2023.
  • Steward Financial Group left its Genmab share count unchanged in Q3 2023.
  • Genmab made up ﹤0.01% of Steward Financial Group's portfolio in Q3 2023, its #306 holding.
  • Steward Financial Group first reported a position in Genmab in Q2 2022 and has held it in 3 quarters since.
  • Steward Financial Group's Genmab position peaked at $15K in Q2 2023.
  • 233 funds tracked by Wall St. Rank held Genmab as of Q3 2023.

Based on Steward Financial Group's 13F filing for Q3 2023, filed 23 Oct 2023.